Use of 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives in leukemia management

Details for Australian Patent Application No. 2008333215 (hide)

Owner Johannes Gutenberg-Universitat Mainz

Inventors Dannhardt, Gerd; Heidel, Florian; Fischer, Thomas; Kramb, Jan-Peter; Plutizki, Stanislav

Agent Freehills

Pub. Number AU-A-2008333215

PCT Pub. Number WO2009/071620

Priority 07023588.2 05.12.07 EP

Filing date 4 December 2008

Wipo publication date 11 June 2009

International Classifications

A61K 31/404 (2006.01)

A61K 31/437 (2006.01)

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/071620 Priority application(s): WO2009/071620

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333219-Blocking layer

2008333208-Vaccine